Is Cannabidiol (CBD) an effective antipsychotic?

24281909498_a080b71a94_k

Luke Sheridan Rains publishes his debut blog on a recent multicentre RCT of Cannabidiol (CBD) as an adjunctive therapy for people with schizophrenia, which suggests that CBD had a beneficial, but modest impact on positive psychotic symptoms and severity of illness when used alongside existing antipsychotics.

[read the full story...]

Periodontitis- supportive periodontal treatment

shutterstock_2584741

This Cochrane review of the effects of supportive periodontal therapy (SPT) in the maintenance of the dentition of adults treated for periodontitis included 4 RCTs providing is insufficient evidence to determine the superiority of different protocols or adjunctive strategies to improve tooth maintenance during SPT.

[read the full story...]

Antidepressants for bipolar depression: weighing up the benefits and harms

7347845622_508b764a51_k

Murtada Alsaif considers a recent systematic review on the safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression.

[read the full story...]

Adding antidepressants to antipsychotics in schizophrenia: do they work, for what, and are they safe?

7687091514_3bffb55cb0_k

Alex Langford explores the emerging findings from a recent meta-analysis looking at the efficacy and safety of antidepressants added to antipsychotics for people with schizophrenia and schizophrenia-like psychosis.

[read the full story...]

Little research on non-surgical interventions to accelerate orthodontic treatment

iStock_000002551343XSmall colourful braces on teeth

With orthodontic treatment lasting typically 18-24 months, adjunts to accelerate tooth movements would be welcome. This Cochrane review identified two RCTs on non-surgical interventions to accelerate orthodontic treatment. However, both studies were at high risk of bias, so we cannot rely on their findings.

[read the full story...]